Foreseen Biotechnology

We innovate for patients

Taipei, Taiwan · Founded 2021

Headquarters
Taipei
Employees
11–50
Founded
2021
Business Model
B2B

About

Foreseen Biotechnology is a precision medicine company founded in 2021 by proteomics leader Catherine C.L. Wong and backed by Sequoia China. The company has built a proprietary high-throughput proteomics and multi-omics platform — including SurfSEEN for membrane-protein discovery and PrOmics for AI-assisted target prioritization — to identify novel, clinically translatable disease targets. Its pipeline spans oncology, autoimmune, and neurological diseases, with lead program FS001 (IPN60300), a first-in-class antibody-drug conjugate, licensed to Ipsen in 2024 and currently in Phase I/II clinical trials in the US and Europe.

Summary

Foreseen Biotechnology is a Biotech company based in Taipei, Taiwan, founded in 2021.

Similar Companies